Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$55.74 +0.44 (+0.79%)
Closing price 03:59 PM Eastern
Extended Trading
$55.74 -0.01 (-0.02%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Advanced

Key Stats

Today's Range
$55.17
$56.59
50-Day Range
$52.47
$70.26
52-Week Range
$51.24
$89.37
Volume
550,089 shs
Average Volume
461,003 shs
Market Capitalization
$2.64 billion
P/E Ratio
14.75
Dividend Yield
N/A
Price Target
$76.50
Consensus Rating
Hold

Company Overview

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 86% of companies evaluated by MarketBeat, and ranked 82nd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 3 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Prestige Consumer Healthcare has a consensus price target of $76.50, representing about 37.2% upside from its current price of $55.75.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has only been the subject of 1 research reports in the past 90 days.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 5.29% in the coming year, from $4.54 to $4.78 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 14.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.56.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 14.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.04.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 1.65. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 1.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    4.93% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 3.48, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently decreased by 14.58%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 39.75% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.

  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Prestige Consumer Healthcare this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for PBH on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $65,930.00 in company stock.

  • Percentage Held by Insiders

    1.40% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBH Stock News Headlines

Premium Brands: I Waited A Year For This Dip
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $61.69 at the beginning of 2026. Since then, PBH stock has decreased by 9.6% and is now trading at $55.7450.

Prestige Consumer Healthcare Inc. (NYSE:PBH) released its quarterly earnings data on Thursday, February, 5th. The company reported $1.14 earnings per share for the quarter, missing analysts' consensus estimates of $1.16 by $0.02. The company's quarterly revenue was down 2.4% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Prestige Consumer Healthcare include Boston Trust Walden Corp (1.36%), Leeward Investments LLC MA (0.80%), Bank of New York Mellon Corp (0.66%) and Principal Financial Group Inc. (0.56%). Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
2/05/2026
Today
5/05/2026
Next Earnings (Estimated)
5/13/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Personal Products
Current Symbol
NYSE:PBH
CIK
1295947
Employees
540
Year Founded
1996

Price Target and Rating

High Price Target
$88.00
Low Price Target
$66.00
Potential Upside/Downside
+37.2%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.78
Trailing P/E Ratio
14.75
Forward P/E Ratio
12.28
P/E Growth
1.65
Net Income
$214.60 million
Net Margins
16.90%
Pretax Margin
24.17%
Return on Equity
12.02%
Return on Assets
6.41%

Debt

Debt-to-Equity Ratio
0.58
Current Ratio
3.11
Quick Ratio
1.93

Sales & Book Value

Annual Sales
$1.14 billion
Price / Sales
2.32
Cash Flow
$5.27 per share
Price / Cash Flow
10.57
Book Value
$37.04 per share
Price / Book
1.50

Miscellaneous

Outstanding Shares
47,320,000
Free Float
46,657,000
Market Cap
$2.64 billion
Optionable
Optionable
Beta
0.40

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:PBH) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners